Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study - Petri, M; Wallace, DJ; Spindler, A (Arthritis Rheum, 2013)
et al.